Enhancing cell-based immunotherapy
AssigneeAnawrahta Biotech Co., Ltd.
InventorsShih-Jen Liu, Wei-Yu Lo
Life of this patent
Estimating the term…
Abstract
An immunogenic composition containing antigen-presenting cells and a heat shock protein or a heat shock fusion protein. Also disclosed is a method of using such a composition for enhancing cell-based immunotherapy, especially cancer immunotherapy. The method includes administering the composition to a target site.
Claims35
A method for enhancing cell-based immunotherapy comprising administering antigen-presenting cells and a heat shock protein or a heat shock fusion protein to a target site.
A method for enhancing cell-based immunotherapy comprising administering antigen-presenting cells expressing a heat shock protein or a heat shock fusion protein to a target site.
A method for enhancing cell-based immunotherapy comprising administering antigen-presenting cells to a target site, wherein pre-existing cells at the target site have been manipulated to express a heat shock protein or a heat shock fusion protein.
An immunogenic composition comprising antigen-presenting cells, a heat shock protein or a heat shock fusion protein, and a pharmaceutically acceptable carrier.
An immunogenic composition comprising antigen-presenting cells expressing a heat shock protein or a heat shock fusion protein, and a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.